UBC PiMS Research Group (the Tremlett Laboratory)
Pharmacoepidemiology in Multiple Sclerosis Research Group (the Tremlett Laboratory)

Alumni

 

Charity Evans

Past Academic Status: Postdoctoral Fellow

Project: Long-term Benefits and Adverse Effects of Beta-interferon for Multiple Sclerosis

 

 

Hilda de Jong

Past Academic Status: Postdoctoral Fellow

Projects: The BeAMS study: The long-term Benefits and Adverse effects of Beta-interferon for Multiple Sclerosis, New indications for old drugs: Do statins, angiotensin converting enzyme inhibitors (ACEIs) or proton pump inhibitors (PPIs) impact long-term disease progression in MS?

 

Kaarina Kowalec

Past Academic Status: PhD Trainee

Project: Genotype specific approaches to preventing adverse drug reactions in multiple sclerosis

 

 

Ellen Lu

Past Academic Status: PhD Trainee

Project: Perinatal outcomes in multiple sclerosis

 

 

Kyla McKay

Past Academic Status: PhD Trainee

Project: Using linked health data to explore the epidemiology and impact of mental health in multiple sclerosis

 

 

Suresh Menon

Past Academic Status: Postdoctoral Fellow

Project: The extremes of disease: the epidemiology of ‘aggressive’ and ‘benign’ multiple sclerosis

 

 

Afsaneh Shirani

Past Academic Status: Postdoctoral Fellow

Projects: Long-term Benefits and Adverse Effects of Beta-interferon for Multiple Sclerosis, Temporal Trends of Disability Progression in Patients with MS, Temporal Pattern of Demographic Changes in Patients with MS

 

 

Mohammad Ehsanul Karim (Ehsan)

Past Academic Status: PhD Trainee

Project: Long-term Benefits and Adverse Effects of Beta-interferon for Multiple Sclerosis

 

 

nedaNeda Razaz-Rahmati

Past Academic Status: PhD Trainee

Project: Children of Parents with Multiple Sclerosis

 

 

 

 

Tingting Zhang

Past Academic Status: Postdoctoral Fellow

Project: Disease progression in multiple sclerosis

 

Jose WijnandsJose Wijnands

Past Academic Status: Postdoctoral Fellow

Project: The PrOMS study: explore and establish the existence of symptomatic prodromal phase(s) in MS

 

 

 

Solmaz Setayeshgar

Past Academic Status: Postdoctoral Fellow

Project: Assessing safety monitoring in patients taking oral MS treatments (ASYMPTOTE)

 

Huah Shin Ng

Past Academic Status: Post-Doctoral Research Fellow

Previous Academic Training: PhD in Pharmacy, BPharm (Hons) [both University of South Australia, Australia].

Professional Registrations: Board Certified Pharmacotherapy Specialist (BCPS, Board of Pharmacy Specialty), Accredited Pharmacist (2015-2019, The Society of Hospital Pharmacist of Australia), Registered Pharmacist (Pharmacy Board of Australia, Singapore Pharmacy Council & Pharmacy Board of Malaysia).

Project: Disease-Modifying Drug Safety and Effectiveness in Multiple Sclerosis (DRUMS)

 

Dr. Floriane Calocer

Past Academic Status: Post-Doctoral Research Fellow

Previous Academic Training: PharmD-Pharmacist, PhD in Epidemiology, University of Caen (France)

Research Interest: MS Epidemiology and Socioeconomic determinants of health.

Project: SMS: Influence of Socioeconomic Status on survival in Multiple Sclerosis (MS) patients.

Dr. Jonas Graf

Past Academic Status: Post-Doctoral Research Fellow

Previous Academic Training: Medical Doctor, Heinrich-Heine University Düsseldorf

Research Focus: Clinical Neuroimmunology and Epidemiology

 

 

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada
Email:

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia